GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » HLB Genex Inc (XKRX:187420) » Definitions » Net Income From Continuing Operations

HLB Genex (XKRX:187420) Net Income From Continuing Operations : ₩-17,749 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is HLB Genex Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. HLB Genex's net income from continuing operations for the three months ended in Mar. 2025 was ₩-1,179 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-17,749 Mil.

HLB Genex Net Income From Continuing Operations Historical Data

The historical data trend for HLB Genex's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Genex Net Income From Continuing Operations Chart

HLB Genex Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12,124.66 -8,526.14 -13,373.14 -721.75 -17,932.73

HLB Genex Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,363.28 391.55 -504.42 -16,456.59 -1,179.34

HLB Genex Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-17,749 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HLB Genex Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » HLB Genex Inc (XKRX:187420) » Definitions » Net Income From Continuing Operations
Comparable Companies
XKRX:036640 XKRX:170920 XKRX:311390 XKRX:074430 XKRX:445180 XKRX:171120 XKRX:136410 XKRX:036670 XKRX:049550 XKRX:420570 LIN XPAR:AI SHW ECL APD ISX:TPIA XSWX:GIVN XSWX:SIKA OCSE:NSIS B XAMS:DSFIR
Traded in Other Exchanges
N/A
Address
65, Techno 1-ro, Yuseong-gu, Daejeon, KOR, 34014
Website
http://www.genofocus.com
HLB Genex Inc, formerly GenoFocus Inc is a high-throughput protein evolution company engaged in the development, manufacture, and distribution of enzymes like Lactazyme, chitizyme, and lipase. It develops enzyme solutions for specialty food, eco-friendly processes, biopharmaceuticals, cosmeceuticals, and agriculture.

HLB Genex Headlines

No Headlines